Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

What were the historical radiation fields and dose for treatment of benign tonsillitis?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · UMass Memorial Medical Group

The majority of patients treated under this indication were children in the late 1940s, 1950s and early 1960s. The prevailing thought at the time was that the irradiation of the tonsils and adenoids would help clear acute and chronic inflammation, and "atrophize" the resultant hyper-plastic lymphoid...

How do you manage grade 3 enterocolitis from 5FU mitomycin and pelvic radiotherapy?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · The Oregon Clinic-Radiation Oncology West

With infection ruled out and CT showing diffuse enterocolitis extending far beyond the bowel-sparing IMRT radiotherapy field, presumably, it is due to the 5FU/mitomycin. In the few cases I have had, it generally heals 2-3 weeks after counts nadir. Besides supportive care (Imodium, Lomotil, Gas-X, ti...

How does a diffusely positive PSMA in the prostate affect treatment planning in a patient with MRI and biopsy showing only one area of disease?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · David Geffen School of Medicine at UCLA

There are three parts to my answer: First, mild to moderate PSMA uptake can be seen in benign conditions, including BPH and prostatitis (e.g., reviewed by Satapathy et al., PMID 32755196). Second, I don't see how the discrepancy between PSMA PET and MRI/biopsy would affect radiation treatment planni...

How would you manage a non-surgical poorly differentiated neuroendocrine tumor of unknown primary with a bulky nodal conglomerate causing pain?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cedars-Sinai Medical Center

This is a question that could have many reasonable answers. Depending on PS, site, symptoms, and overall onc plan - many standard palliative regimens could be deployed, including more aggressive palliative if this were the only (known) site of disease and more durable local control is intended. Also...

Would you cover elective nodal regions in a patient with high-risk cutaneous SCC of the right medial forehead with clinically negative lymph nodes s/p WLE with graft?

4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Bon Secours Mercy Health

This patient exhibits several adverse features that could warrant post-operative management. As a caveat, patient KPS and other factors may influence the decision point on if and what to treat. That said, the tumor size, thickness, and the presence of other high-risk features in aggregate (+PNI/LVSI...

What is the significance of grade in OPSCC?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic

Multiple groups have found an association between the impact of fractionation schedule on outcome and tumor differentiation using high quality prospective data (Eriksen et al., PMID 14751528, Bentzen et al., PMID 16110017, Lyhne et al., PMID 26255764). Well-diff and to a lesser extent moderate-diff ...

How would you manage a recurrent anaplastic supratentorial ependymoma in an adult?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Florida International University

There is no well-defined standard-of-care approach for previously irradiated, now recurrent ependymoma, in any setting, whether it is adult or pediatric, cranial or spinal, and supra vs. infratentorial. Unfortunately, the natural history at this stage is characterized by multiple relapses, each with...

What dose and setup would be recommended for isolated penile shaft metastasis from bladder cancer?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

If this is isolated oligometastatic disease, I would treat it as if it were a skin cancer. If superficial and can be removed easily, this is a reasonable option. If not, then can consider a dose of 55 Gy in 20 fractions utilizing a direct electron field or orthovoltage if available. If the patient h...

How would you approach a locally advanced anorectal melanoma with local progression after 4 cycles of nivolumab and ipilimumab who is not a surgical candidate?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic School of Medicine

For non-operative management of anorectal melanoma, I most commonly use radiotherapy with a regimen of 30 Gy in 5 fractions delivered every other day vs twice weekly (Ballo et al., PMID 11958890; Kelly et al., PMID 21446049). The disease burden, in this case, sounds quite extensive in which case a...

Would you offer post op adjuvant radiation following keloid resection if it would result in a significant dose being delivered to the patient's thyroid gland?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

This is less of a "medical" answer than one about patient values. As a specialty, we are remarkably conservative, especially when it comes to benign disease (see our reluctance to treat osteoarthritis, compared to other nations). Post-op treatment of keloids is essentially an aesthetic choice. We kn...